Magainin Pharm (MAGN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Magainin Pharm (MAGN)

MAGN 8.625

-2.1%

9:43 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Dave K who wrote (156)	10/30/1998 5:20:00 PM
From: Shlepper	Read Replies (1) of 233

Hi Dave, The people at Magainin have indicated that the squalamine is a good candidate for cocktail cancer treatments. The toxicity is so low, that high dosaging does not seem to be a problem. I guess that we'll need to wait another 6 months or so before the stock picks up appreciably. we should be getting results from the squalamine early in '99, so that may also give us a boost. Keep up the good research, Shep

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next